Aytu Biopharma (AYTU) Asset Utilization Ratio (2013 - 2026)

Aytu Biopharma (AYTU) has 14 years of Asset Utilization Ratio data on file, last reported at 0.48 in Q1 2026.

• On a quarterly basis, Asset Utilization Ratio fell 11.56% year-over-year to 0.48 in Q1 2026; TTM through Mar 2026 was 0.48, a 11.56% decrease from a year earlier, with the FY2025 full-year figure at 0.55, up 7.0% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.48, down from 0.51 in the prior quarter.
• Over the last five years, Asset Utilization Ratio for AYTU reached as high as 0.76 in Q2 2023 and fell as low as 0.47 in Q1 2022.
• Historically, Asset Utilization Ratio has averaged 0.6 across 5 years, with a median of 0.55 in 2025.
• Across the five-year window, Asset Utilization Ratio jumped 137.29% in 2022 and slumped 30.28% in 2024, its largest moves.
• Year by year, Asset Utilization Ratio stood at 0.72 in 2022, then dropped by 5.92% to 0.68 in 2023, then retreated by 22.36% to 0.53 in 2024, then decreased by 4.17% to 0.51 in 2025, then declined by 4.5% to 0.48 in 2026.
• Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.48 in Q1 2026, 0.51 in Q4 2025, and 0.51 in Q3 2025.